These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35545330)

  • 41. Metformin Enhances the Effect of Regorafenib and Inhibits Recurrence and Metastasis of Hepatic Carcinoma After Liver Resection via Regulating Expression of Hypoxia Inducible Factors 2α (HIF-2α) and 30 kDa HIV Tat-Interacting Protein (TIP30).
    Yang Q; Guo X; Yang L
    Med Sci Monit; 2018 Apr; 24():2225-2234. PubMed ID: 29654226
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Metformin induces apoptosis in hepatocellular carcinoma Huh-7 cells in vitro and its mechanism].
    Lin F; Yan W; Wen T; Wu GY
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):742-6. PubMed ID: 24378094
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination of metformin and sorafenib suppresses proliferation and induces autophagy of hepatocellular carcinoma via targeting the mTOR pathway.
    Ling S; Song L; Fan N; Feng T; Liu L; Yang X; Wang M; Li Y; Tian Y; Zhao F; Liu Y; Huang Q; Hou Z; Xu F; Shi L; Li Y
    Int J Oncol; 2017 Jan; 50(1):297-309. PubMed ID: 27959383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of Metformin Use With Cancer-Specific Mortality in Hepatocellular Carcinoma After Curative Resection: A Nationwide Population-Based Study.
    Seo YS; Kim YJ; Kim MS; Suh KS; Kim SB; Han CJ; Kim YJ; Jang WI; Kang SH; Tchoe HJ; Park CM; Jo AJ; Kim HJ; Choi JA; Choi HJ; Polak MN; Ko MJ
    Medicine (Baltimore); 2016 Apr; 95(17):e3527. PubMed ID: 27124061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Negative regulation of Sirtuin 1 by AMP-activated protein kinase promotes metformin-induced senescence in hepatocellular carcinoma xenografts.
    Zhou X; Chen J; Chen L; Feng X; Liu Z; Hu L; Zeng Z; Jia X; Liang M; Shi B; Yi G; Liu J
    Cancer Lett; 2017 Dec; 411():1-11. PubMed ID: 28964787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Diagnosis and treatment of hepatocellular carcinoma].
    Spangenberg HC; Zuber-Jerger I; Mohr L; Thimme R; Blum HE
    Dtsch Med Wochenschr; 2004 Feb; 129(8):368-72. PubMed ID: 14961445
    [No Abstract]   [Full Text] [Related]  

  • 47. Metformin enhances radiosensitivity in hepatocellular carcinoma by inhibition of specificity protein 1 and epithelial-to-mesenchymal transition.
    Zhang KF; Wang J; Guo J; Huang YY; Huang TR
    J Cancer Res Ther; 2019; 15(7):1603-1610. PubMed ID: 31939444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metformin-Loaded Hyaluronic Acid-Derived Carbon Dots for Targeted Therapy against Hepatocellular Carcinoma by Glutamine Metabolic Reprogramming.
    Ghosh A; Ghosh AK; Zaman A; Das PK
    Mol Pharm; 2023 Dec; 20(12):6391-6406. PubMed ID: 37933877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metformin exerts anti-tumor effects via Sonic hedgehog signaling pathway by targeting AMPK in HepG2 cells.
    Hu A; Hu Z; Ye J; Liu Y; Lai Z; Zhang M; Ji W; Huang L; Zou H; Chen B; Zhong J
    Biochem Cell Biol; 2022 Apr; 100(2):142-151. PubMed ID: 34990285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Metformin and malignant neoplasms: a possible mechanism of antitumor action and prospects for use in practice].
    Kuznetsov KO; Safina ER; Gaimakova DV; Frolova YS; Oganesyan IY; Sadertdinova AG; Nazmieva KA; Islamgulov AH; Karimova AR; Galimova AM; Rizvanova EV
    Probl Endokrinol (Mosk); 2022 Jul; 68(5):45-55. PubMed ID: 36337018
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30.
    Guo Z; Cao M; You A; Gao J; Zhou H; Li H; Cui Y; Fang F; Zhang W; Song T; Li Q; Zhu X; Sun H; Zhang T
    Cancer Sci; 2016 Apr; 107(4):507-13. PubMed ID: 26752068
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metformin inhibits tumor growth and affects intestinal flora in diabetic tumor-bearing mice.
    Kang J; Li C; Gao X; Liu Z; Chen C; Luo D
    Eur J Pharmacol; 2021 Dec; 912():174605. PubMed ID: 34757071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
    Hsieh SC; Tsai JP; Yang SF; Tang MJ; Hsieh YH
    Amino Acids; 2014 Dec; 46(12):2809-22. PubMed ID: 25245054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metformin promotes apoptosis in hepatocellular carcinoma through the CEBPD-induced autophagy pathway.
    Tsai HH; Lai HY; Chen YC; Li CF; Huang HS; Liu HS; Tsai YS; Wang JM
    Oncotarget; 2017 Feb; 8(8):13832-13845. PubMed ID: 28099155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of UXT in tumors and prospects for its application in hepatocellular carcinoma.
    Wang Z; Mo S; Han P; Liu L; Liu Z; Fu X; Tian Y
    Future Oncol; 2022 Sep; 18(29):3335-3348. PubMed ID: 36000398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Research Progress of Metformin in the Treatment of Oral Squamous Cell Carcinoma.
    Liu J; Zhao J; Qiao X
    Endocrinology; 2023 Sep; 164(11):. PubMed ID: 37738154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metformin inhibits early stage diethylnitrosamine‑induced hepatocarcinogenesis in rats.
    Jo W; Yu ES; Chang M; Park HK; Choi HJ; Ryu JE; Jang S; Lee HJ; Jang JJ; Son WC
    Mol Med Rep; 2016 Jan; 13(1):146-52. PubMed ID: 26548419
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of hepatocellular carcinoma: from prevention to molecular targeted therapy.
    Kudo M
    Oncology; 2010 Jul; 78 Suppl 1():1-6. PubMed ID: 20616576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancement of Radiation Response Associated With Metformin in Hepatocellular Carcinoma: Preclinical Animal and Clinical Cohort Study.
    Jang WI; Kim MS; Jeong JH; Kim W; Kim JS
    Anticancer Res; 2022 Feb; 42(2):867-876. PubMed ID: 35093884
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metformin leads to accumulation of reactive oxygen species by inhibiting the NFE2L1 expression in human hepatocellular carcinoma cells.
    Gou S; Qiu L; Yang Q; Li P; Zhou X; Sun Y; Zhou X; Zhao W; Zhai W; Li G; Wu Y; Ren Y; Qi Y; Zhang Y; Gao Y
    Toxicol Appl Pharmacol; 2021 Jun; 420():115523. PubMed ID: 33838154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.